CLINICAL ROLE -
Inflammatory Bowel Disease
Continuity of Care: Pneumonia: Targeting Treatments and Monitoring the Response
Pneumonia and influenza together represent the seventh leading cause of death in the United States. Pharmacists can influence care by ensuring that appropriate therapy is initiated quickly and closely monitoring patients.
Treatment Goals for Drug-Resistant Tuberculosis
Tuberculosis remains a major global health concern?it is important for the pharmacist to focus on patient medication adherence to avoid drug resistance.
Helping Hepatitis Patients Manage Their Disease
Pharmacists can improve care of patients with hepatitis B or C through recommendations, monitoring, and education.
Continuity of Care: Treating the Cataract Patient
PEP for HIV, Hepatitis B, and Hepatitis C May Reduce Risk
Dr. Grandinetti is a senior clinical research pharmacist at the National Cancer Institute, National Institutes of Health, Rockville, Md. The views expressed are those of the author and not those of any government agency.
Many Potential Sources for Drug-induced Rhabdomyolysis
The views expressed are those of the author and not those of any government agency.
2 Clarke Drive Cranbury, NJ 08512